Alzecure Pharma Stock Number Of Employees
| ALZCUR Stock | SEK 1.08 0.06 5.26% |
AlzeCure Pharma fundamentals help investors to digest information that contributes to AlzeCure Pharma's financial success or failures. It also enables traders to predict the movement of AlzeCure Stock. The fundamental analysis module provides a way to measure AlzeCure Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AlzeCure Pharma stock.
AlzeCure |
AlzeCure Pharma Company Number Of Employees Analysis
AlzeCure Pharma's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current AlzeCure Pharma Number Of Employees | 14 |
Most of AlzeCure Pharma's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AlzeCure Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, AlzeCure Pharma is currently employing 14.0 people. This is 99.87% lower than that of the Healthcare sector and 99.69% lower than that of the Drug Manufacturers - Specialty & Generic industry. The number of employees for all Sweden stocks is 99.93% higher than that of the company.
AlzeCure Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AlzeCure Pharma's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AlzeCure Pharma could also be used in its relative valuation, which is a method of valuing AlzeCure Pharma by comparing valuation metrics of similar companies.AlzeCure Pharma is currently under evaluation in number of employees category among its peers.
AlzeCure Fundamentals
| Return On Equity | -1.55 | |||
| Return On Asset | -0.78 | |||
| Current Valuation | 173.51 M | |||
| Shares Outstanding | 59.19 M | |||
| Shares Owned By Insiders | 41.31 % | |||
| Shares Owned By Institutions | 6.48 % | |||
| Price To Book | 6.62 X | |||
| EBITDA | (77.2 M) | |||
| Net Income | (77.78 M) | |||
| Cash And Equivalents | 222.05 M | |||
| Cash Per Share | 5.88 X | |||
| Current Ratio | 48.05 X | |||
| Book Value Per Share | 0.63 X | |||
| Cash Flow From Operations | (70.64 M) | |||
| Earnings Per Share | (1.78) X | |||
| Target Price | 11.88 | |||
| Number Of Employees | 14 | |||
| Beta | 0.76 | |||
| Market Capitalization | 254.44 M | |||
| Total Asset | 45.65 M | |||
| Z Score | -3.3 | |||
| Net Asset | 45.65 M |
About AlzeCure Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AlzeCure Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AlzeCure Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AlzeCure Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in AlzeCure Stock
AlzeCure Pharma financial ratios help investors to determine whether AlzeCure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzeCure with respect to the benefits of owning AlzeCure Pharma security.